BPCC2012 Vision

Over the past three years, CDMC Events’ biopharma conference series such as World Clinical Research Organization Summit 2010, Pharma Innovate Asia Taiwan 2010, China Vaccine Focus 2011, World Antibody Focus 2011 etc. have been well received and acclaimed by global participants. In 2012, enlightened by China’s “12th Five Year Plan” on biopharma industry, CDMC Events will present you BioPharma China Convention 2012-Vaccine & Antibody Focuson June 20th-21st in Beijing China with the theme of “Upgrading China’s BioPharma Industry through Innovation and Collaboration”. It is committed to provide a content-rich, critically-focused event with the aim of helping biopharma decision makers and scientists obtain insights into global biopharma trends, China market strategies, partnering & investment opportunities, frontiers in vaccine and antibody R&D, manufacturing & production excellence etc.

Shake Hands with and Listen to World Class Speakers

  • Vaccine Stream Antibody Stream
    Xiaoping DONG
    The Chinese Center for Disease Control and Prevention (CCDC)
    Xinliang SHEN
    Chairman, ABO
    Executive Committee Vice President of China National Biotech Group
    JIN Yulan
    Changchun Institute of Biological Products
    Sean DU
    Head & Executive Director,
    Vaccine Research Simcere Pharmaceutical Groups
    Haifa ZHENG
    General Manager
    Beijing Minhai Biotechnology Co., Ltd
    Xiaoqiang (Alex) LI
    General Manager
    TASLY& JENNER (Tianjin) Co., LTD
    Nicholas JACKSON
    Senior Director
    Pfizer Vaccine Research
    Jean-Denis SHU
    Medical Director
    Sanofi Pasteur Biological Products Co. Ltd.
    Xiang (Sam) LIAO
    Head Business Development& Licensing
    Asia Novartis Vaccines & Diagnostics, Inc.
    Tim Hirst
    Executive Chairman
    Gamma Vaccines
    BIA Separations
    Samuel THONG
    Managing Director
    Morgan Stanley
    YAO Jun
    Director of the Planning Department
    MIIT (Ministry of Industry and Information Technology)
    Prof. GUO Yajun
    Chinese National Engineering
    Research Center for Antibody
    ZHANG Aihua
    Vice Director R&D Department
    China National
    Biotech Group
    Dr. ZHANG
    Lianshan Global R&D President
    Jiangsu Hengrui Medicine Co,.Ltd
    Corporate Senior Vice President
    Boehringer Ingelheim (BI)
    Shirley ZHAO
    General Manager
    Genzyme China
    XIA Mingde, Ph.D.
    Senior Director
    COSAT Johnson& Johnson
    Dr. John L. XU
    Associate Director,
    Biologics GSK R&D China
    Patrick A. BAEUERLE
    Senior Vice President
    Chief Scientific Office Micromet
    ZHU Zhenping
    Kadmon China
    Jin-San YOO
    President and Founder PharmAbcine,
    Inc., Korea
    Andrew BUCHANAN PhD
    Senior Scientist and Team Leader

WHY BPCC-See what your peers said:

  • Very nice meeting. Thank organizers very much for the great effort. One of the best vaccine focus conference in china.
    SHEN Xinliang, Deputy General Manager, China National Biotech Group
  • This is a high quality international conference with excellent group of speakers & participants. Very well organized, provided enough opportunity for people to interact. Looking forward to the future events.
    GUO Yajun, Director, Chinese National Engineering Research Centre for Antibody Medicine
  • Excellent conference with great mix of speakers. It provided good platform to learn for scientists who are antibody experts and new in the field. Plenty opportunities to interact with old friends and to meet new ones.
    ZHU Zhenping, EVP, Kadmon Pharmaceuticals
  • This is a very exciting events, with participants from both academia and pharma industry. There is something new for both new-comers to the therapeutics Ab fields and veterans in the industry as well. Great networking opportunities!
    Dr. John L. Xu, Associate Director, Biologics, GSK R&D China
  • Very professionally organized, good questions and knowledgeable topics.
    Dr. Klaus WILGENBUS, Corporate Senior Vice President, Boehringer Ingelheim
  • It has been great to find out more detail on the biopharmacautical industry in China.
    Andrew Buchanan, Senior Team Leader & Scientist, MedImmun

Conference Structure

DAY 1, June 20, Wednesday

DAY 2, June 21, Tuesday

AM Global Outlook & China Strategies Concurrent one-on-one meetings Vaccine Stream: Antibody Stream  Concurrent one-on-one meetings
PM Partnering & Investment Opportunities

See what your can benefit:

  • Gaining knowledge of latest information about biopharma and detailed incentive policy of local government
  • Talking face-to-face and networking with governmental officials, professionals and scientists home and abroad
  • Hosting one-on-one meetings with your potential business partners and promote your business
  • Sharing with your peers the latest ideas on biopharma development
  • Having an opportunity to publicize your company and future plan